Вы находитесь на странице: 1из 1

Jan 12th,

Drug Information Centre Service 2010

Introduction to DIC Also classified based on types of activities offered, space


“Drug information is an Unbiased, well referred, critically available, budget, staff, resources.
evaluated up to date information on any aspect of drug”. The
first formalized DIC, established in 1962 at the University of Sources of drug information
Kentucky, served as a prototype for other institutions. Primary sources: Are the foundation on which all other drug
Function of Drug Information Center is to provide a system information is based. Evaluating primary literature is
for the organization and dissemination of drug information difficult. The most reliable evidence comes from reports on
(Francke 1965).Access to clinically relevant, up-to-date, user- randomized controlled trials. Proper evaluation of these trials
specific, independent, objective, and unbiased drug requires considerable experience, and systematic reviews of
information is essential for appropriate drug use. Prescribers, combined trials (meta-analyses) may be necessary.
dispensers, and users of medicines all need objective • Medical and therapeutic journals – eg. New England
information. A health care system can provide access to the journal of medicine.
highest- quality medicines, but if those medicines are not
properly used, they may have negligible benefits or even
• Drugs and toxicology information and pharmacology
journals – eg. European journal of clinical pharmacology.
adverse effects. Although access to good drug information
does not guarantee appropriate drug use, it is certainly a basic • Pharmacy journals – eg. Annals of pharmacotherapy
requirement for rational drug use decisions. Secondary information resource: Are essentially derivations
of the primary literature. Examples of such services include
Medline, Current Contents, and International Pharmaceutical
Functions of DIC Abstracts
• Pharmacy & Therapeutics committee: This Committee Tertiary references, written by individuals or groups, are
formulates and reviews policies regarding the selection, often developed with the input of consultant reviewers and
intra-hospital distribution, storage, and safe use and may be widely peer reviewed. Eg. Essential drug list and
administration of drugs within the Hospital. therapeutic formularies DIC in India
• Drug Usage Review (DUR)/ Evaluation Manufacturers' Promotional Information Drug information • Increasing patient load on doctors
• Adverse Drug Reporting program provided by manufacturers is secondary or tertiary • Mostly present in pharma industry which provide info
• Investigational Drug program information. The type and quality of information provided by about specific company products
• Education and training drug manufacturers vary considerably from country to • Lack of unbiased information centres
• Publication (Newsletter, bulletins, journals) country, depending on governments' regulations and ability to Features influencing DIC in India:
• Community Services enforce them. 1. Growth of clinical pharmacy education and practice
• 5Rs – Right drug, Right dose, Right dosage form, Right 2. Growth of information technology
route and Right Patient. 3. Focus on EBM
• Drug Interaction Enquiries at Shionogi DIC, Japan 4. Complexity of drug use
• Availability/ Substitute 5. Patient awareness
• Drug identification • Edu inst. DIC: eg. Hindu Pharmacy, Goa
• Formulary decision • Independent DIC: eg. DIC, MSPC, Maharashtra
• Compatibility • Hospital attached DIC: eg. Poison Info. Center,
• Toxicity & poisoning AIIMS
• Drugs in pregnancy & lactation.
Conclusion
Types of DICs 1.Drug information center is one of the essential services of
health care professionals
2.Providing Drug information services is necessary for the
survival of the pharmacy profession
3.Drug Information Services help in effective and efficient
drug therapy and consequently a better patient care will be
achieved
4.Dissemination of information is still a problematic and
pharmacists should coordinate and work towards that goal.

CLINICAL PHARMACY ASSIGNMENT. Roll nos. 21-30, MBA Pharm. Tech. 4th year, SPTM, NMIMS

Вам также может понравиться